Natera stock forecast 2026–2028
Analysts' average 12-month price target for Natera is 393.16, 26.7% above the current price of 310.29. Their targets range from 245.00 to 500.00.
Of the 16 firms that rated Natera in the past 12 months, 14 rate it buy or strong buy, 2 hold and 0 sell or strong sell (each firm at its latest rating): a Strong buy consensus.
Analysts' 1-year price targets range from 245.00 to 500.00, with an average of 393.16.
| Strong buy | 0 | |
| Buy | 14 | |
| Hold | 2 | |
| Sell | 0 | |
| Strong sell | 0 |
12-month price target
| Highest target | 500.00 |
| Average target | 393.16 |
| Lowest target | 245.00 |
| Current price | 310.29 |
Natera price target history
Have analysts recently raised or lowered their Natera price target and rating?
How analysts rate Natera, month by month
14 of 16 firms rate it buy now, against 14 of 15 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Natera analyst upgrades, downgrades and price targets
The latest rating change came on 5 June 2026, when Goldman Sachs downgraded Natera from Buy to Neutral. Its price target is 245.00. The most recent new target came from Piper Sandler on 6 November 2026: 363.50.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 6 Nov 2026 | Piper Sandler Dave Westenberg | — | 249.00 → 363.50 | +46.0% | 310.68 |
| 27 Oct 2026 | BTIG Mark Massaro | Reiterated · Buy | 320.00 → 430.00 | +34.4% | 404.90 |
| 22 Oct 2026 | Roth Capital | — | 475.00 | — | 401.37 |
| 19 Oct 2026 | Canaccord Genuity | Reiterated · Buy | 375.00 → 500.00 | +33.3% | 393.44 |
| 12 Oct 2026 | Morgan Stanley | — | 355.00 → 435.00 | +22.5% | 400.64 |
| 7 Oct 2026 | Barclays | Reiterated · Overweight | 340.00 → 475.00 | +39.7% | 400.65 |
| 1 Oct 2026 | Guggenheim | Reiterated · Buy | 360.00 → 475.00 | +31.9% | 418.12 |
| 25 Sept 2026 | RBC Capital | Reiterated · Outperform | 350.00 → 460.00 | +31.4% | 409.70 |
| 9 Sept 2026 | UBS | Reiterated · Buy | 260.00 → 435.00 | +67.3% | 324.14 |
| 8 Sept 2026 | Redburn Partners | — | 385.00 | — | 328.18 |
| 12 Aug 2026 | Stephens | Reiterated · Overweight | 350.00 | — | 317.25 |
| 12 Aug 2026 | Guggenheim | Reiterated · Buy | 290.00 → 360.00 | +24.1% | 312.72 |
| 10 Aug 2026 | Morgan Stanley | — | 310.00 → 355.00 | +14.5% | 323.58 |
| 7 Aug 2026 | RBC Capital | Reiterated · Outperform | 275.00 → 350.00 | +27.3% | 316.14 |
| 7 Aug 2026 | Robert W. Baird Catherine Ramsey Schulte | — | 265.00 → 348.00 | +31.3% | 265.38 |
| 7 Aug 2026 | Canaccord Genuity Kyle Mikson | — | 330.00 → 375.00 | +13.6% | 265.38 |
| 7 Aug 2026 | Wells Fargo | Reiterated · Equal Weight | 220.00 → 284.00 | +29.1% | 265.38 |
| 7 Aug 2026 | BTIG | Reiterated · Buy | 275.00 → 320.00 | +16.4% | 265.38 |
| 7 Aug 2026 | Leerink Partners | — | 330.00 | — | 265.38 |
| 7 Aug 2026 | Barclays | — | 270.00 → 340.00 | +25.9% | 265.38 |
| 14 Jul 2026 | Canaccord Genuity | Reiterated · Buy | 285.00 → 330.00 | +15.8% | 272.89 |
| 9 Jul 2026 | Morgan Stanley | Reiterated · Overweight | 265.00 → 310.00 | +17.0% | 274.39 |
| 6 Jul 2026 | Evercore ISI | Reiterated · Outperform | 270.00 → 300.00 | +11.1% | 281.26 |
| 29 Jun 2026 | Guggenheim Subbu Nambi | Reiterated · Buy | 270.00 → 290.00 | +7.4% | 261.91 |
| 24 Jun 2026 | BTIG | Reiterated · Buy | 270.00 → 275.00 | +1.9% | 260.72 |
| 24 Jun 2026 | UBS | — | 280.00 → 260.00 | -7.1% | 234.76 |
| 23 Jun 2026 | BTIG | Reiterated · Buy | 270.00 | — | 234.76 |
| 11 Jun 2026 | RBC Capital Dan Leonard | — | 268.00 → 275.00 | +2.6% | 219.23 |
| 5 Jun 2026 | Goldman Sachs Evie Koslosky | Downgraded · Buy → Neutral | 245.00 | — | 222.10 |
| 12 May 2026 | Piper Sandler | — | 249.00 | — | 199.14 |
| 8 May 2026 | Robert W. Baird | — | 265.00 | — | 201.13 |
| 8 May 2026 | Evercore ISI | Reiterated · Outperform | 270.00 | — | 200.20 |
| 8 May 2026 | Wells Fargo Brandon Couillard | Reiterated · Equal Weight | 205.00 → 220.00 | +7.3% | 219.82 |
| 5 Jan 2026 | Guggenheim | Reiterated · Buy | 270.00 | — | 230.65 |
| 22 Dec 2025 | Canaccord Genuity | Reiterated · Buy | 195.00 → 285.00 | +46.2% | 231.96 |
| 15 Dec 2025 | Wells Fargo | Reiterated · Equal Weight | 175.00 → 205.00 | +17.1% | 231.88 |
| 15 Dec 2025 | Barclays | Reiterated · Overweight | 270.00 | — | 231.88 |
| 1 Dec 2025 | Morgan Stanley | — | 195.00 → 265.00 | +35.9% | 234.25 |
| 18 Nov 2025 | UBS | Reiterated · Buy | 280.00 | — | 213.65 |
Natera EPS and revenue estimates
Revenue
EPS
Does Natera beat earnings estimates?
On average, analysts' EPS estimate was 40.5% off the result, either way, and their revenue estimate 13.6%, over the last 12 quarters.
- EPS beats
- 24 / 46
- Revenue beats
- 31 / 46
- Average EPS surprise, last 12
- +16.1%
- Since
- August 2015
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 5 Nov 2026 | -0.28 | -0.42 | -49.3% | 707.54M | 793.98M | +12.2% |
| Q2 FY2026 | 6 Aug 2026 | -0.49 | -0.47 | +4.8% | 661.24M | 752.75M | +13.8% |
| Q1 FY2026 | 7 May 2026 | -0.54 | -0.56 | -3.3% | 617.10M | 696.64M | +12.9% |
| Q4 FY2025 | 26 Feb 2026 | -0.51 | 0.35 | +168.4% | 604.04M | 665.50M | +10.2% |
| Q3 FY2025 | 6 Nov 2025 | -0.39 | -0.64 | -65.9% | 513.45M | 592.18M | +15.3% |
| Q2 FY2025 | 7 Aug 2025 | -0.62 | -0.74 | -20.2% | 476.26M | 546.60M | +14.8% |
| Q1 FY2025 | 8 May 2025 | -0.64 | -0.50 | +21.9% | 446.23M | 501.83M | +12.5% |
| Q4 FY2024 | 27 Feb 2025 | -0.38 | -0.41 | -7.6% | 435.64M | 476.06M | +9.3% |
| Q3 FY2024 | 12 Nov 2024 | -0.57 | -0.26 | +54.4% | 361.43M | 439.76M | +21.7% |
| Q2 FY2024 | 8 Aug 2024 | -0.69 | -0.30 | +56.5% | 343.00M | 413.35M | +20.5% |
| Q1 FY2024 | 9 May 2024 | -0.71 | -0.56 | +21.1% | 316.31M | 367.74M | +16.3% |
| Q4 FY2023 | 28 Feb 2024 | -0.73 | -0.64 | +12.3% | 300.00M | 311.11M | +3.7% |
Most undervalued US stocks
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 99.090 | 195.09146Price 99.09244 | +96.9% | |
| 186.680 | 359.93270Price 186.68450 | +92.8% | |
| 213.670 | 405.66304Price 213.67507 | +89.9% | |
| 161.160 | 305.51157Price 161.16396 | +89.6% | |
| 42.225 | 79.0244Price 42.23157 | +87.1% | |
| 160.650 | 299.85225Price 160.65375 | +86.6% | |
| 108.445 | 201.41108Price 108.45248 | +85.7% |
Furthest below the fair value on each stock's page, updated every day.
